Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Drop in Short Interest

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 762,900 shares, a decline of 50.3% from the January 31st total of 1,536,000 shares. Based on an average daily volume of 1,764,000 shares, the short-interest ratio is presently 0.4 days.

Bayer Aktiengesellschaft Stock Performance

BAYRY traded up $0.36 during trading on Monday, hitting $6.29. 806,870 shares of the company traded hands, compared to its average volume of 1,026,612. Bayer Aktiengesellschaft has a one year low of $4.79 and a one year high of $8.58. The stock's fifty day moving average is $5.40 and its 200 day moving average is $6.30. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The firm has a market cap of $24.72 billion, a P/E ratio of -24.19 and a beta of 1.04.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.